Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Moderna's updated COVID-19 vaccine for Autumn 2023 outperforms in cost and clinical impact

Moderna's updated mRNA-1273.815 COVID-19 vaccine shows promising results in reducing symptomatic cases, hospitalizations, and deaths in high-risk and older adults in Germany. The study finds the vaccine to be more cost-effective and clinically beneficial than both no vaccination and Pfizer's XBB.1.5 BNT162b2 vaccine.

12 Oct 2023

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

The research paper explores the multifaceted role of the IL-17 family in immune response, covering everything from infection control to pathological conditions like autoimmune diseases and cancer. Future therapies may exploit IL-17's unique signaling pathways to offer more targeted and cost-effective treatments.

12 Oct 2023

EVScape: New tool to forecast which SARS-CoV-2 variants could dodge our immunity

Researchers have developed EVScape, a predictive tool that identifies which SARS-CoV-2 strains are most likely to evade host immunity. Utilizing a deep generative model and structural information, the tool offers early warning about viral variants, aiding in the timely development of effective vaccines and treatments.

12 Oct 2023

Genetic causes of Raynaud’s phenomenon identified

Researchers at Queen Mary University of London’s Precision Healthcare Research Institute (PHURI) and the Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin have identified the genetic causes of Raynaud’s phenomenon. Their findings, published today (12 October) in Nature Communications, could lead to the first effective treatments for people with Raynaud’s.

12 Oct 2023

Elderly and vulnerable people at risk from low home temperatures, warns Lilli

Interventions are needed to urgently prevent elderly and vulnerable people from putting their health at risk, with temperatures inside some homes reaching as low as 5C last winter, says Lilli, the SaaS company using a proactive care lifestyle monitoring technology to revolutionise care.

12 Oct 2023

OrganaBio launches new division to meet growing demand for decentralized clinical trial support

OrganaBio, the Contract Technology Development and Manufacturing Organization (CTDMO) specializing in solutions for cell and immunotherapy development, today announces the official launch of Cell Processing and Cryopreservation (CPC) Services, a new division of OrganaBio.

12 Oct 2023

UVA scientists’ efforts could help better combat antibiotic-resistant bacteria

University of Virginia researchers are working to outrace two dangerous germs known for quickly developing resistance to new antibiotics – and the scientists’ efforts could help us better combat antibiotic resistance more broadly.

12 Oct 2023

Genetically edited chickens show resistance to avian influenza in landmark study

Researchers use CRISPR technology to create chickens resistant to avian influenza, targeting specific genes to inhibit viral replication. The study reveals both the promise and complexities of using genetic editing as a disease control strategy, also shedding light on influenza's adaptability.

11 Oct 2023

Maternal pertussis vaccination boosts infant protection up to eight months

In a large-scale Australian study, maternal vaccination during pregnancy significantly increased pertussis resistance in infants up to eight months. While it slightly reduced the effectiveness of infants' routine vaccinations, it did not increase infection risk.

11 Oct 2023

New AI tool predicts future viral variants using evolutionary, biological information

The COVID-19 pandemic seemed like a never-ending parade of SARS-CoV-2 variants, each equipped with new ways to evade the immune system, leaving the world bracing for what would come next.

11 Oct 2023

Does renting accelerate biological aging? New study sparks housing policy debate

Living in privately rented homes is linked to faster biological aging, with its impact nearly double that of unemployment. However, these effects are reversible, highlighting the potential of housing policies in health improvement.

10 Oct 2023

UVA researchers take on antibiotic resistance crisis with $1.2 million grant

University of Virginia researchers are working to outrace two dangerous germs known for quickly developing resistance to new antibiotics – and the scientists' efforts could help us better combat antibiotic resistance more broadly.

10 Oct 2023

Comparing the lasting effects: post COVID vs. non-COVID acute respiratory infections

Symptom profiles between individuals with prior COVID-19 and those with other acute respiratory infections (ARIs).

10 Oct 2023

RSV in seniors: Less common than COVID-19, but hits harder, CDC study reveals

In a recent CDC's MMWR study, researchers found that while respiratory syncytial virus (RSV) infections are less common than COVID-19 and influenza in Americans aged 60+ years, they result in much more severe clinical outcomes. This insight supports the CDC's recommendation for RSV vaccination in older adults, emphasizing its potential in preventing severe respiratory disease.

10 Oct 2023

1918 flu's true victims were not the fittest, but the most stressed

Analyzing remains of 1918 influenza pandemic victims, researchers from McMaster University and the University of Colorado Boulder found that the flu's most susceptible victims showed signs of prior environmental, nutritional, and social stress. Contrary to historical beliefs, the study, published in PNAS, revealed that those in poor health were more likely to succumb to the pandemic than healthy individuals.

9 Oct 2023

Compound found to inhibit influenza virus replication by targeting host enzyme

How can the propagation of influenza viruses be stopped? For a new approach in the therapy of influenza infections, Prof. Hiroki Kato from the Institute of Cardiovascular Immunology at the University Hospital Bonn (UKB) and the Cluster of Excellence ImmunoSensation2 of the University of Bonn receives an Open Philanthropy grant of 2.2 million US dollars.

9 Oct 2023

Study finds non-nutritive sweetened beverages more effective than water for weight loss

BIOVECTRA signs service agreement with Acuitas Therapeutics for unique lipid nanoparticle (LNP) delivery system used in manufacturing mRNA-based therapies

BIOVECTRA and Acuitas Therapeutics, Inc. today announced that they have entered into a technology transfer service.

From BIOVECTRA 6 Oct 2023

Previous
1
...
43
44
45
46
47
48
49
...
1167
Next

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Moderna's updated COVID-19 vaccine for Autumn 2023 outperforms in cost and clinical impact

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

EVScape: New tool to forecast which SARS-CoV-2 variants could dodge our immunity

Genetic causes of Raynaud’s phenomenon identified

Elderly and vulnerable people at risk from low home temperatures, warns Lilli

OrganaBio launches new division to meet growing demand for decentralized clinical trial support

UVA scientists’ efforts could help better combat antibiotic-resistant bacteria

Genetically edited chickens show resistance to avian influenza in landmark study

Maternal pertussis vaccination boosts infant protection up to eight months

New AI tool predicts future viral variants using evolutionary, biological information

Does renting accelerate biological aging? New study sparks housing policy debate

UVA researchers take on antibiotic resistance crisis with $1.2 million grant

Comparing the lasting effects: post COVID vs. non-COVID acute respiratory infections

RSV in seniors: Less common than COVID-19, but hits harder, CDC study reveals

1918 flu's true victims were not the fittest, but the most stressed

Compound found to inhibit influenza virus replication by targeting host enzyme

Study finds non-nutritive sweetened beverages more effective than water for weight loss

People may experience 'long colds' after acute respiratory infections, study finds

Inhaled nitric oxide shows promise as treatment for COVID-19 respiratory failure

BIOVECTRA signs service agreement with Acuitas Therapeutics for unique lipid nanoparticle (LNP) delivery system used in manufacturing mRNA-based therapies

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in